American Healthcare REIT, Inc.
NYSE:AHRREIT - Healthcare Facilities
-$0.35 today
- Market cap
- $13.59B
- Beta
- 0.81
- P/E (TTM)
- 86.9
- EPS (TTM)
- $0.54
- Dividend yield
- 2.15%
Volume 2.30M
Average 2.50M
AHR Stock-Based Compensation
Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.
American Healthcare REIT, Inc.NYSE: AHR
Stock-Based Compensation · Q3 FY2026 · quarter ended Sep 2026
Stock-based compensation growth accelerates
Q3 FY2026 stock-based compensation of $9.28M rose 170.7% year over year, ahead of the +126.3% change in trailing-twelve-month stock-based compensation. Sequentially, it rose 61.0% from the prior quarter. Over 3 fiscal years it compounded at +55.2% a year.
Context
- Stock-based compensation amounted to 0.6% of revenue in FY2025, up 0.2 pp from a year earlier.
- Stock-based compensation increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +170.7% holds above the trailing-twelve-month pace of +126.3%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Stock-Based Compensation history
USD · from the cash flow
- Latest · FY2025
- 14.62M USD
- Year-over-year change
- +48.1%
- 4-year CAGR
- +10.9%
| Period | Period end | Stock-Based Compensation | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 14.62M | +48.1% |
| FY2024 | 2024-12-31 | 9.87M | +80.5% |
| FY2023 | 2023-12-31 | 5.47M | +39.9% |
| FY2022 | 2022-12-31 | 3.91M | -59.5% |
| FY2021 | 2021-12-31 | 9.66M | — |
Stock-Based Compensation vs competitors
How AHR compares with its peers on the latest reported figures
- AHR's LTM Sep 2026 stock-based compensation of $25.36M is the 3rd largest of the 11 companies compared; the peer median is $8.97M.
- Its year-over-year change of +126.3% is the 5th highest of 9, against a peer median of +268.6%.
- Stock-based compensation amounts to 0.9% of revenue for AHR, versus a peer median of 1.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $1.56B | +2425.8% | +290.5% | 11.4% | |
| LTM Jun 2026 | $53.19M | +476.0% | +17.4% | 4.1% | |
| LTM Sep 2026 | $25.36M | +126.3% | +55.2% | 0.9% | |
| LTM Sep 2026 | $22.59M | +61.2% | -18.3% | 1.0% | |
| LTM Jun 2026 | $13.13M | +24.6% | +15.1% | 1.5% | |
| LTM Sep 2026 | $11.87M | +9.0% | +27.4% | 1.9% | |
| LTM Sep 2026 | $6.06M | — | — | 1.3% | |
NHPBPNational Healthcare Properties, Inc. | LTM Mar 2026 | $4.38M | +1043.1% | +47.0% | 1.3% |
NHPNational Healthcare Properties, Inc. (NHP) | LTM Dec 2025 | $3.77M | — | — | 1.1% |
| LTM Mar 2026 | $3.2M | +4350.0% | — | 2.0% | |
MPTMedical Properties Trust, Inc. | LTM Jun 2026 | $2.4M | -93.2% | -19.5% | 0.2% |
| Peer median (excluding AHR) | $8.97M | +268.6% | +17.4% | 1.4% | |
Competitors are the stored peer set for AHR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (53.27M) | (73.38M) | (76.89M) | (35.6M) | 70.82M |
| Depreciation & Amortization | 157.38M | 200.6M | 237.3M | 221.64M | 225.2M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | (22.94M) |
| Stock-Based Compensation | 9.66M | 3.91M | 5.47M | 9.87M | 14.62M |
| Change in Working Capital | (93.47M) | (37.8M) | (55.79M) | (68.68M) | (30.32M) |
| Accounts Receivables | 3.69M | (4.46M) | (34.72M) | (23.75M) | (13.05M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | (39.71M) | 13.88M | 15.43M | (653K) | 29.01M |
| Other Working Capital | (57.45M) | (47.22M) | (36.49M) | (44.28M) | (46.29M) |
| Other Non-Cash Items | (2.39M) | 54.44M | (11.55M) | 48.86M | 37.06M |
| Operating Cash Flow | 17.91M | 147.77M | 98.54M | 176.09M | 294.44M |
| Capital Expenditures | (79.7M) | (71.52M) | (99.79M) | (91.94M) | (128.56M) |
| Acquisitions (Net) | (650K) | (18.57M) | (12.93M) | (235K) | (118.84M) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (58.31M) | (28.49M) | 122.11M | 83.44M | (835.89M) |
| Investing Cash Flow | (138.65M) | (118.58M) | 9.4M | (8.73M) | (1.08B) |
| Debt Repayment | 146.31M | 62.83M | (17.59M) | (995.45M) | (160.45M) |
| Common Stock Issued | 0 | 0 | 0 | 1.36B | 1.15B |
| Common Stock Repurchased | (382K) | (20.7M) | (469K) | (14K) | 238K |
| Dividends Paid | (22.79M) | (51.12M) | (76.28M) | (120.9M) | (163.52M) |
| Other Financing Activities | (29.04M) | (33.93M) | (34.72M) | (382.64M) | (4.98M) |
| Financing Cash Flow | 94.11M | (42.92M) | (129.06M) | (134.74M) | 817.5M |
| Effect of Forex Changes | (74K) | 154K | 7K | (91K) | 62K |
| Net Change in Cash | (26.7M) | (13.58M) | (21.12M) | 32.52M | 28.45M |
| Free Cash Flow | (61.78M) | 76.25M | (1.26M) | 84.15M | 165.88M |
American Healthcare REIT, Inc.
NYSE:AHR
Intrinsic Alpha fair value
Locked
Current Price
$58.55
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.